The prevalence of nodular regenerative hyperplasia of the liver in long-term thiopurine-treated inflammatory bowel disease patients

Lennard P L Gilissen*, Rudaba Tajzai, Marielle Romberg, Marieke Pierik, Arnold Stronkhorst, Karin Steenhuisen, Ad Van Bodegraven, Alette Daniels, Dennis Wong

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Web of Science)
Original languageEnglish
Pages (from-to)e102-e107
Number of pages6
JournalEuropean Journal of Gastroenterology & Hepatology
Volume33
Issue number1S Suppl 1
DOIs
Publication statusPublished - 1 Dec 2021

Keywords

  • hepatotoxicity
  • inflammatory bowel disease
  • nodular regenerative hyperplasia
  • thiopurine
  • LOW-DOSE 6-THIOGUANINE
  • IBD PATIENTS
  • 6-MERCAPTOPURINE THERAPY
  • AZATHIOPRINE
  • THIOGUANINE
  • HEPATOTOXICITY
  • SAFETY
  • ASSOCIATION
  • INTOLERANT
  • TOXICITY

Cite this